SELVAS Healthcare, Inc. (KOSDAQ:208370)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,280.00
-10.00 (-0.44%)
At close: Oct 23, 2026

SELVAS Healthcare Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
31,69130,82531,70229,81327,68629,089
Revenue Growth
0.04%-2.77%6.34%7.68%-4.83%37.52%
Gross Profit
15,55214,99816,56115,65013,98513,853
Operating Income
1,560-161.563,2753,3492,4863,416
Net Income
8,6983,8893,1525,1702,8132,472
Earnings Per Share
340.04151.00122.00214.0094.38114.00
EPS Growth
337.34%23.77%-42.99%126.75%-17.21%225.71%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medical Diagnosis Division
17,93317,59819,42315,75213,85116,852
Assistive Technology Division
15,66015,45514,95316,81913,83512,238
Consolidation Adjustment
-1,902-2,229-2,673-2,758--
Total
31,69130,82531,70229,81327,68629,089

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27,57426,37626,08924,2807,06114,872
Total Debt
2,5901,7252,9963,2397,83316,753
Net Cash (Debt)
24,98324,65223,09221,041-771.46-1,881
Net Cash Growth
27.40%6.75%9.75%---
Net Cash Per Share
976.46955.37894.97870.30-32.65-86.85

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,964304.754,5003,47250.812,928
Capital Expenditures
-1,663-856.8-716.31-359.64-352.31-371.2
Free Cash Flow
1,302-552.043,7833,112-301.512,557
Free Cash Flow Growth
-29.99%-21.57%---37.46%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.07%48.66%52.24%52.50%50.51%47.62%
Operating Margin
4.92%-0.52%10.33%11.23%8.98%11.74%
Pretax Margin
30.49%15.74%10.41%12.94%10.30%8.72%
Profit Margin
27.45%12.62%9.94%17.34%10.16%8.50%
FCF Margin
4.11%-1.79%11.93%10.44%-1.09%8.79%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
6.7138.4233.0933.9016.0926.29
Forward PE
-20.3020.3020.3020.3020.30
P/FCF Ratio
45.05-27.5656.31-25.41
PS Ratio
1.854.853.295.881.642.23